Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact on Quality of Life of Novel Glucose -Sensing Technology Used by Individuals With Type 2 Diabetes on Intensive-insulin Therapy

NCT02809365 is registered in ClinicalTrials.gov with Wolfson Medical Center as lead sponsor.

NCT NCT02809365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact on Quality of Life of Novel Glucose -Sensing Technology Used by Individuals With Type 2 Diabetes on Intensive-insulin Therapy
Lead sponsor
Wolfson Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
October 31, 2017
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes